achiko logo.png


Achiko (SWX: ACHI), listed on the Switzerland Stock Exchange during the year, is transforming into a health technology company with the rapid development of Teman Sehat, an open source software product that provides an alternative way to manage Covid-19 testing, and ‘Gumnuts’, a potential rapid and low-cost virus detection technology.

Achiko is headquartered in Zürich, with offices in Hong Kong, Jakarta, Singapore and Seoul.

Given Gumnuts will be low-cost and user convenient, with the potential to do frequent mass screening of whole populations, it could be considered the jewel in the crown because of the scalable nature of the technology.